We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Tumor volume as prognostic factor in chemoradiation for advanced head and neck cancer.
- Authors
Knegjens, Joost L.; Hauptmann, Michael; Pameijer, Frank A.; Balm, Alfons J.; Hoebers, Frank J.; de Bois, Josien A.; Kaanders, Johannes H.; van Herpen, Carla M.; Verhoef, Cornelia G.; Wijers, Oda B.; Wiggenraad, Ruud G.; Buter, Jan; Rasch, Coen R.
- Abstract
Background. Tumor volume is an important predictor of outcome in radiotherapy alone. Its significance in concomitant chemoradiation (CCRT) is much less clear. We analyzed the prognostic value of primary tumor volume for advanced head and neck squamous cell carcinoma (HNSCC) treated with CCRT. Methods. Three hundred sixty patients treated with definitive CCRT for advanced HNSCC were selected. The pretreatment MRI or CT scan was used to calculate the primary tumor volume. Median follow-up was 19.8 months. Results. The average primary tumor volume was 37.0 cm3 (range, 2.1-182.7 cm3; median, 28.7 cm3). Multivariate analysis showed a significant effect of tumor volume on local control. The hazard ratio for a local recurrence increased by 14% per 10 cm3 volume increase (95% CI, 8% to 21%). There was no significant independent effect of T and N status on local control. Conclusion. For advanced HNSCC, tumor volume is more powerful for predicting outcome after CCRT than TNM status.
- Subjects
HEAD &; neck cancer; SQUAMOUS cell carcinoma; METASTASIS; RADIOTHERAPY; MAGNETIC resonance imaging; MULTIVARIATE analysis; PATIENTS
- Publication
Head & Neck, 2011, Vol 33, Issue 3, p375
- ISSN
1043-3074
- Publication type
Article
- DOI
10.1002/hed.21459